CNBX Pharmaceuticals Inc. (CNBX) Liabilities and Shareholders Equity (2013 - 2026)
CNBX Pharmaceuticals (CNBX) reported Liabilities and Shareholders Equity of $12,795 for fiscal Q3 2026 (quarter ended May 31, 2026), down 31.3% from $18,615 a year earlier and down 14.1% from the prior quarter.
Powered by 
Analysis
CNBX Pharmaceuticals Inc. (CNBX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), CNBX Pharmaceuticals posted Liabilities and Shareholders Equity of $18,437, down 41.3% from FY2024.
- Liabilities and Shareholders Equity has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -61.6% (FY2020 to FY2025).
- By fiscal year, Liabilities and Shareholders Equity came in at $31,383 in FY2024 (-93.7%), $499,039 in FY2023 (-38.5%), $811,166 in FY2022 (-73.7%) and $3.08 million in FY2021 (+38.7%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $11,162 in fiscal Q1 2026 and a high of $3.08 million in fiscal Q4 2021.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last 18 quarters, with an average decline of 65.9% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q4 2021 (growth of 38.7%); the low point was fiscal Q1 2025 (a decline of 94.2%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $14,899 (Q2 2026), $11,162 (Q1 2026) and $18,437 (Q4 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 12,795.00 |
| Feb 28, 2026 | 14,899.00 |
| Nov 30, 2025 | 11,162.00 |
| Aug 31, 2025 | 18,437.00 |
| May 31, 2025 | 18,615.00 |
| Feb 28, 2025 | 50,660.00 |
| Nov 30, 2024 | 22,308.00 |
| Aug 31, 2024 | 31,383.00 |
| May 31, 2024 | 80,027.00 |
| Feb 29, 2024 | 163,917.00 |
| Nov 30, 2023 | 387,402.00 |
| Aug 31, 2023 | 499,039.00 |
| May 31, 2023 | 662,019.00 |
| Feb 28, 2023 | 462,052.00 |
| Nov 30, 2022 | 609,509.00 |
| Aug 31, 2022 | 811,166.00 |
| May 31, 2022 | 965,740.00 |
| Feb 28, 2022 | 1.14 Mn |
| Nov 30, 2021 | 2.12 Mn |
| Aug 31, 2021 | 3.08 Mn |
API Access
CNBX Pharmaceuticals Inc. Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CNBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CNBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CNBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();